{
    "clinical_study": {
        "@rank": "162943", 
        "acronym": "ISR", 
        "arm_group": [
            {
                "arm_group_label": "in-stent restenosis"
            }, 
            {
                "arm_group_label": "non-in-stent restenosis"
            }
        ], 
        "biospec_descr": {
            "textblock": "whole blood"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "The investigators hypothesized that genetic variants of G protein influence the development\n      of restenosis and clinical outcome of patients receiving drug-eluting stents (DES)."
        }, 
        "brief_title": "Genetics Study of In-stent Restenosis", 
        "completion_date": {
            "#text": "September 2012", 
            "@type": "Anticipated"
        }, 
        "condition": "Coronary Artery Disease", 
        "condition_browse": {
            "mesh_term": [
                "Coronary Artery Disease", 
                "Myocardial Ischemia", 
                "Coronary Disease"
            ]
        }, 
        "detailed_description": {
            "textblock": "Although drug-eluting stents (DES) have reduced restenosis rates compared with bare-metal\n      stents, the restenosis rate is still high in the high-risk group. G protein plays important\n      roles in the signal transduction leading to vascular smooth muscle proliferation. The\n      initial and subsequent studies suggest that the T allele of C825T polymorphism is associated\n      with enhanced transmembrane signaling via Gi proteins."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients who underwent follow-up angiography. All the patients must had been\n             implanted with DES during the last two years.\n\n        Exclusion Criteria:\n\n          -  For the non-ISR group, the patients underwent follow-up angiography less than 6\n             months away from stent implanting."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Hospitalized patients"
            }
        }, 
        "enrollment": {
            "#text": "300", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 15, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01670396", 
            "org_study_id": "ZS-XN-ISR"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "coronary stent implant", 
            "polymorphism", 
            "G protein", 
            "drug-eluting stent", 
            "restenosis"
        ], 
        "lastchanged_date": "August 19, 2012", 
        "location": {
            "contact": {
                "email": "xu.yamei@zs-hospital.sh.cn", 
                "last_name": "Yamei Xu", 
                "phone": "8613917133371"
            }, 
            "facility": {
                "address": {
                    "city": "Shanghai", 
                    "country": "China"
                }, 
                "name": "Zhongshan Hospital"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_groups": "2", 
        "official_title": "G Protein \u03b23 Subunit (GNB3) Polymorphism and Restenosis of Coronary Drug-eluting Stents", 
        "overall_contact": {
            "email": "xu.yamei@zs-hospital.sh.cn", 
            "last_name": "Yamei Xu", 
            "phone": "8613917133371"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2012", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "In-stent restenosis", 
            "safety_issue": "Yes", 
            "time_frame": "6-24months after stent implanting"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01670396"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "target lesion revascularization (TLR)", 
                "safety_issue": "Yes", 
                "time_frame": "6-24months after stent implanting"
            }, 
            {
                "measure": "re-myocardial infarction", 
                "safety_issue": "Yes", 
                "time_frame": "6-24months after stent implating"
            }
        ], 
        "source": "Shanghai Zhongshan Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Shanghai Zhongshan Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2012", 
        "study_design": "Observational Model: Case Control, Time Perspective: Retrospective", 
        "study_type": "Observational", 
        "verification_date": "August 2012"
    }
}